GSK's Benefiber Constipation-Relief Claim Supported In Review Following P&G Challenge
Executive Summary
GSK supported claim Benefiber Healthy Balance supplement "helps relieve occasional constipation and abdominal discomfort without causing diarrhea" in challenge by Metamucil marketer P&G. Dispute decided in industry self-regulation form focused on PHGG's mechanism of action in reliving constipation.
You may also be interested in...
GSK Appeals Industry Self-Regulation Forum’s Finding Against Benefiber ‘100% Natural’ Claim
GSK will appeal a finding that it doesn’t support its “100% Natural” claim for Benefiber Original and Healthy Shape. Question asked in the review from a P&G challenge reflects FDA’s ongoing consideration of whether a public health concern will emerge if it doesn’t substantially expand its regulation of use of the term.
Pepto-Bismol Ultra Works As Name But Not For P&G To Claim Twice Original Product's Strength
To understand how Pepto-Bismol Ultra could be considered twice as strong as original as stated on packaging, consumers would need to "carefully review the Drug Facts on the back of both" products and "recognize that the active ingredient in both products is 525 mg of bismuth subsalicylate" but Ultra's dose is half original's.
Citrucel Claim That Metamucil Causes Excess Gas Expelled After 20 Years
GlaxoSmithKline will discontinue claim P&G's Metamucil product causes excess gas and it Citrucel doesn't after P&G presented evidence that met NAD's standard for reopening a review. The industry self-regulation organization found GSK could no longer support its claim.